Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier ...

Researchers sought to determine the effects of high body mass index and low physical activity levels on incidence of subsequent neoplasms in survivors of childhood cancer.

Long-term treatment with ixekizumab does not increase the incidence of malignant neoplasms in patients with psoriasis, PsA, ...

Incidences of malignant neoplasms were low and stable with long-term ixekizumab treatment for people with psoriatic disease ...

Panelists discuss how the future treatment landscape for myeloproliferative neoplasms is evolving with many promising ...

Contributions quantified for subsequent neoplasms in childhood cancer survivors. (HealthDay News) — Cancer treatments and genetic predisposition contribute to the risk of subsequent neoplasms ...

FRIDAY, June 13, 2025 (HealthDay News) -- Cancer treatments and genetic predisposition contribute to the risk of subsequent neoplasms (SNs) among long-term childhood cancer survivors, according to ...

Our findings demonstrate that the mutational landscape of BPDCN is similar to that observed in other myeloid neoplasms, and we identified CCDC50 as a ...

Post-COVID data show that circulatory claims have increased by nearly 60%, while neoplasms remain the leading source of ...